Tomorrow, I start a new role as Sr. Manager in Scientific Communications in the THV team at @EdwardsLifesci. 👩‍💼👩‍💻 @EdwardsLifesci is a global leader in interventions for structural heart disease, critical care and surgical monitoring. I am so excited to join this cause! #scicomm

‼️Exciting Event‼️ The @ECI_ISHR committee is hosting a Winter Webinar Symposia for pre- and post-doctoral trainees. Selected abstracts will present oral talks with the opportunity to win Travel Awards to the 2026 ISHR-NAS conference. See below for more details and submit now!

Please help to repost ⏰⏰⏰ The Tong Lab @UTSWMedCenter is recruiting a postdoctoral fellow to join us in studying the molecular mechanisms of HFpEF and atrial fibrillation. Prior experience in cardiac pathophysiology, immunology and bioinformatics is preferred but not required.

Are you looking for a PhD position and want to spend your summers in the Rocky Mountains? My lab @CUDenver is looking for 1 PhD student to work on a NSF-funded project to study elevational range shifts in Colorado! Apply by Nov 1! Details here

🎉 Congratulations to Dr. Doug Tilley on his promotion to Associate Dean of Faculty Affairs at LKSOM! We’re excited to see his continued leadership in shaping the future of our faculty and advancing academic excellence. 👏

As a Guest Editor for @JoVEJournal, Im organising a Collection titled “Cellular Cross-Talk in the Heart: Experimental Approaches to Cardiac Cell Interactions.” Interested in contributing? Please submit your proposal here: https://t.co/9LdV1tnCRj

I am grateful to be involved as a volunteer ‘Guide’ in the UT system Career Exploration Network, providing personal and professional development advice for PhD students and postdoctoral trainees 'Seekers'. 👩‍🎓🧑‍🎓🤝 Learn more about the program here:

I had a terrific, highly informative time at the @crfheart #NYValves 2025, held in the🩵of NYC. Hot topics included timing of aortic valve replacement in patients living with aortic stenosis without symptoms and latest innovations in structural heart disease. 🩺 🫶

Big updates ahead!💡🫀 Catch late-breaking trial results at #NYValves2025. Get fresh insights on EARLY TAVR, treatment disparities, redo TAVR, new valve technologies, and more! @djc795 @SammyElmariahMD @suzannejbaron @ShinFukuharaMD #CardioResearch #CardioEd #CardioX

🗞️Heart failure and obesity: exploring translational insights and therapeutic strategies. 👉Read the new scientific statement from #HFA_ESC https://t.co/T4j7rjNvDe @EJHFEiC @AmrAbdin10 @GiuseppeGalati_ @HanCardiomd @GianluSava

Latest EARLY TAVR data: Cardiac damage was frequent in pts enrolled in the trial of TAVI in asymptomatic AS, with those treated preemptively more likely to show an improvement in their stage of clinical damage @PhilGenereuxMD #EuroPCR

🎥Hotline #TAVI🔥 at #EuroPCR: Philippe Genereux highlighted findings from the EARLY #TAVR trial, which investigated the incidence, progression, and clinical impact of cardiac damage in patients with asymptomatic severe aortic stenosis. @ABeneduceMD asked him to break down the

Last week to register for the 2025 @AmwaRmc Spring conference - Registration closes 5/22! When: Saturday, June 7 9:00am - 5:00pm MDT Where:  Hyatt Regency Aurora-Denver Conference, Colorado  Register here: https://t.co/b2TSZo912r Registration is $15 for members!

🚨 Calling all #EarlyCareer scientists! 🔬 Want to dive into cutting-edge –omics research? Join top experts from @UCSanDiego, @UWMadison, @UIowa, @CedarsSinai + more! 🗓️ Wed, May 7 | 3–4:15pm EST 🎟️ Free with AHA membership 👉 https://t.co/GAgLKZz7Li #CardioTwitter @AHAScience

Ever want to incorporate -omics techniques into your own research?!?! Tune in for a great AHA @BCVSearlyCareer webinar on this topic. Learn how these cutting edge techniques are transforming our understanding of cardiovascular biology! #cardiotwitter, @AHAScience @ECI_ISHR

Some very exciting news! The FDA has approved TAVR with the @EdwardsLifesci SAPIEN 3 platform to treat patients with asymptomatic, severe aortic stenosis in the U.S. Wonderful news for patients and their loved ones. #lifeisnow #tavr 🫀🙏 https://t.co/VdNQrQban4

Our lab has identified a new epigenetic mechanism and a druggable target in #HFpEF. Extremely thankful to my amazing team and our fantastic collaborators! @CircRes @UZH_en @Unispital_USZ @CTECresearch @PaneniLab https://t.co/fRPEfpJ9s0

🔥#ACC25 Late-Breaking Trials: Primary biomarker analysis from the EARLY TAVR Trial 🔗 https://t.co/Y6DJ9YAkTd @AsherElad reviews this trial 📊that studied cardiac biomarkers in patients with asymptomatic severe aortic stenosis. #TAVI #TAVR #interventionalcardiology

Save the Date for the next @AmwaRmc virtual networking event! 🖥️ 🤝 When: Thursday March 20, 5:30 to 6:30 PM MT Registration is required: https://t.co/06F5FRwDS3 There will be speed networking, games, and more! 🙌

This #JACCINT analysis of the combined PARTNER2 & PARTNER3 trials included 1,355 patients undergoing #TAVI & demonstrated excellent & comparable outcomes at 5yrs between patients w/ small vs large aortic annuli https://t.co/jWFNnOLE0K #TAVR @hahn_rt @MartyBLeon @PPibarot @djc795

American Heart Association highlights importance of NIH as battle over Trump funding cuts continues @American_Heart @CircAHA @STS_CTsurgery #NIH